Cardio Diagnostics Holdings Files 8-K, Releases Aug 2026 Investor Presentation

What Happened
Cardio Diagnostics Holdings, Inc. (CDIO) filed an 8-K on August 20, 2026 (Item 7.01, Regulation FD Disclosure) stating that senior management will begin using the materials included as Exhibit 99.1 — the "Cardio Diagnostics Holdings, Inc. August 2026 Investor Presentation" — in presentations to existing and prospective investors. The filing also includes the exhibits under Item 9.01, notably Exhibit 99.1 and the cover page interactive data file (Exhibit 104).

Key Details

• Effective date: August 20, 2026, management will start using the Investor Presentation in investor presentations.
• Exhibit 99.1: "Cardio Diagnostics Holdings, Inc. August 2026 Investor Presentation" is attached to the 8-K.
• Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Exhibits) were reported in this filing.

Why It Matters
This 8-K signals that the company has an updated investor presentation that management will rely on when communicating with investors and analysts. For retail investors, the slide deck is the primary new disclosure in the filing — review Exhibit 99.1 to see the company’s latest messaging, metrics, or outlook as presented by management. The Regulation FD notice indicates the company is making this material publicly available to ensure fair disclosure.